Section I
171 – 180 of 5014
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Identifying prognostic targets in metastatic prostate cancer beyond AR
- Contribution to journal › Article
-
Mark
Statin Therapy in Early Breast Cancer : The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo
- Contribution to journal › Article
-
Mark
Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study
- Contribution to journal › Article
-
Mark
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer : A study protocol of ARIADNE
- Contribution to journal › Article
-
Mark
Neutrophil infiltration in peritoneal metastasis affects prognosis in patients with ovarian cancer
- Contribution to journal › Article
-
Mark
Incidence and risk factors for postoperative vaginal events following radical cystectomy for bladder cancer : a nationwide population-based study
- Contribution to journal › Article
-
Mark
Primary treatment and survival in malignant ovarian germ cell tumors : A nationwide population-based Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
- Contribution to journal › Article
-
Mark
Seizure-Related Homolog Protein 6 (SEZ6) : Biology and Therapeutic Target in Neuroendocrine Carcinomas
- Contribution to journal › Scientific review
-
Mark
MicroRNA-379 Modulates Prostate-Specific Antigen Expression Through Targeting the Androgen Receptor in Prostate Cancer
- Contribution to journal › Article
